DALLABONA, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 2.557
EU - Europa 2.226
AS - Asia 1.345
SA - Sud America 63
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
Totale 6.218
Nazione #
US - Stati Uniti d'America 2.528
IT - Italia 718
CN - Cina 622
SG - Singapore 543
SE - Svezia 442
IE - Irlanda 424
FI - Finlandia 206
DE - Germania 117
FR - Francia 69
BR - Brasile 58
UA - Ucraina 58
TR - Turchia 56
GB - Regno Unito 52
RU - Federazione Russa 48
BD - Bangladesh 41
BE - Belgio 29
IN - India 28
CA - Canada 24
AT - Austria 21
HK - Hong Kong 13
NL - Olanda 11
CI - Costa d'Avorio 10
ES - Italia 8
PK - Pakistan 8
IR - Iran 7
EU - Europa 6
ID - Indonesia 6
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
LT - Lituania 4
PT - Portogallo 4
KE - Kenya 3
MA - Marocco 3
MX - Messico 3
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
LK - Sri Lanka 2
PL - Polonia 2
TW - Taiwan 2
UZ - Uzbekistan 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.218
Città #
Dublin 413
Chandler 376
Santa Clara 367
Singapore 302
Parma 194
Ann Arbor 172
Ashburn 148
Dearborn 142
Boardman 137
Beijing 132
Jacksonville 83
Shanghai 82
Nanjing 79
Princeton 69
Izmir 54
New York 52
Wilmington 43
Moscow 41
Los Angeles 36
Helsinki 32
Des Moines 31
Jinan 30
Brussels 28
Nanchang 28
Shenyang 27
Milan 26
San Mateo 26
Bologna 25
Woodbridge 25
Kunming 22
Marseille 22
Nuremberg 21
Hebei 18
Toronto 18
Changsha 16
Colchester 15
Guangzhou 15
Hangzhou 15
Hefei 15
Falls Church 14
Tianjin 14
Redmond 13
Rome 13
Seattle 13
Catania 12
Zhengzhou 12
Fontanellato 11
Vienna 11
Abidjan 10
Piacenza 10
Bremen 9
Houston 9
Pistoia 9
Bari 8
Dallas 8
Norwalk 8
Pune 8
Vicenza 8
Gravina di Catania 7
Hong Kong 7
Vezzano sul Crostolo 7
Bengaluru 6
Carpi 6
Council Bluffs 6
Dosolo 6
Haikou 6
Jakarta 6
Washington 6
Frankfurt am Main 5
Grafing 5
Langhirano 5
Mardan 5
Munich 5
Newcastle Upon Tyne 5
Ottawa 5
Reggio Nell'emilia 5
Trezzano Sul Naviglio 5
Arnstadt 4
Avola 4
Baku 4
Benevento 4
Brescia 4
Cagliari 4
Ferrara 4
Glen Mills 4
Jiaxing 4
Messina 4
Ningbo 4
Padova 4
Pisa 4
Ravenna 4
Redwood City 4
Scafati 4
São Paulo 4
Zanjan 4
Belo Horizonte 3
Cascina 3
Chengdu 3
Chongqing 3
Este 3
Totale 3.772
Nome #
Yeast as a model system to shed light on the role of the human disease protein Mpv17 124
DNA polymerase [gamma] and disease: what we have learned from yeast 124
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 124
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 118
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 115
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 111
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 111
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 106
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 106
Yeast as a model system for diseases associated with defective coenzyme a metabolism 105
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 105
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 101
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 100
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 96
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 95
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 95
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 94
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 93
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 92
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 91
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 91
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 88
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 87
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 87
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 86
SYM1, l'ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 86
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 85
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 85
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 84
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 84
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 84
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 84
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 83
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 82
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 82
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 80
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 79
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 79
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 79
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 79
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 77
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 77
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 76
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 76
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 75
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 74
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 74
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 73
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 72
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 72
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 71
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 70
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 69
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 69
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 67
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 67
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 67
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 66
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 65
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 64
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 64
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 62
The power of yeast in modeling human mutations leading to mitochondrial disease 61
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 59
Role of ROS in mtDNA instability in ANT1-associated adPEO 57
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 57
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 56
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 56
Mitochondrial diseases and the role of the yeast models. 56
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 56
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 55
Novel (ovario) leukodystrophy related to AARS2 mutations 52
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 44
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 43
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 43
Yeast-based screening to discover therapies for Complex III assembly defects. 40
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 40
Epigenetic analyses in forensic medicine: future and challenges 39
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 37
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 31
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 31
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 27
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 26
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 23
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 22
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 20
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 19
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 18
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 17
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 17
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 17
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 15
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 14
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 12
Totale 6.487
Categoria #
all - tutte 24.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.379


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 0 0 75 55 23 25
2020/2021463 8 22 46 5 48 31 23 23 106 61 53 37
2021/2022407 22 21 1 27 14 27 36 37 14 33 28 147
2022/20231.478 141 151 102 96 136 157 28 83 505 7 51 21
2023/2024764 57 66 37 29 58 146 39 64 17 74 66 111
2024/20251.677 44 91 123 143 291 388 142 116 339 0 0 0
Totale 6.487